Corsera Raises $80M as First Preventative Heart Disease Program Moves Into Clinic

The cardiovascular biotech was also named as one of BioSpace’s top startups to watch on Wednesday.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top